The prestigious innovation award recognizes the Tria™ Stent's first-of-a-kind tri-layer design and proprietary surface technology, created with patient safety in mind.

At 32, Nicole given six months to live after her cancer diagnosis. But a treatment called TheraSphere™ changed everything. Watch her story.

Deep brain stimulation therapy can bring symptom relief from Parkinson's and help people live their best lives. Read Erica and Samran's stories.

Brooke, a competitive athlete, thought she was permanently sidelined by the risks of her heart arrthythmia. But with her ICD device, she now runs epic distances across New Zealand.

David Knapp, vice president of R&D for the Peripheral Interventions Vascular team, talks about the crucial ingredients for innovation in this Q&A.

What happens when a radiation oncologist receives his own cancer diagnosis?

When Rob learned he was at risk of sudden cardiac arrest, his doctor suggested he immediately receive an implantable cardioverter defibrillator (ICD device).

With the growing prevalence of neurological disorders, from Parkinson’s and chronic pain to Alzheimer’s, rapid innovation in neuromodulation is more important than ever.

Digital health solutions that connect patients to the care they need have tremendous promise to help reduce healthcare disparities.

The Health Economics and Market Access (HEMA) group at Boston Scientific works to ensure that patients have access to innovative healthcare treatments.